ArticleLife sciences2016
Linagliptin reduces effects of ET-1 and TLR2-mediated cerebrovascular hyperreactivity in diabetes.
Trevor Hardigan et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
8 papers cite it
this papercites it
ArticleLife sciences2016
Trevor Hardigan et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.